Current Gastroenterology Reports

, Volume 3, Issue 1, pp 79–83 | Cite as

Kidney disease in patients with chronic hepatitis c

  • Marie Philipneri
  • Bahar Bastani


There is an increasing recognition of the association between chronic hepatitis C virus infection and glomerular diseases. Renal complications may be the presenting manifestation of hepatitis C virus infection. Patients may present with signs and symptoms of cryoglobulinemic systemic vasculitis, proteinuria, microscopic hematuria, acute renal failure, or nephrotic syndrome. The pathogenesis of hepatitis C virus associated with renal disease remains incompletely understood; however, deposition of circulating immune complexes in the subendothelial space and mesangium in the glomeruli seems to play a major role. The most common renal pathology associated with hepatitis C virus infection is type I membranoproliferative glomerulonephritis with or without cryoglobulinemia. In patents who do not have significant renal impairment, combination therapy with interferon alfa (IFN-α) and ribavirin seems to be the treatment of choice, although the experience with this combination is quite limited in patients with renal involvement. A prolonged course of high-dose IFN-α has been most commonly used for these patients with significant success, but relapse of hepatitis C viremia and renal disease after discontinuation of therapy have frequently occurred.


Glomerulonephritis Membranous Nephropathy Cryoglobulinemia Mixed Cryoglobulinemia Membranoproliferative Glomerulonephritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Amico G, Colasanti G, Ferrario F, Sinico RA: Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989, 35:1004–1014.PubMedGoogle Scholar
  2. 2.
    Harle J, Disder P, Dussol B, et al.: Membranoproliferative glomerulonephritis and hepatitis C infection. Lancet 1993, 341:904.PubMedCrossRefGoogle Scholar
  3. 3.
    Doutrelepont JM, Adler M, Willens M, Yap SH: Hepatitis C infection and membranoproliferative glomerulonephritis. Lancet 1993, 341:317.PubMedCrossRefGoogle Scholar
  4. 4.
    Yamabe H, Johnson RJ, Gretch DR, et al.: Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995, 6:220–223.PubMedGoogle Scholar
  5. 5.
    Johnson RJ, Gretch DR, Yamabe H, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993, 328:465–470.PubMedCrossRefGoogle Scholar
  6. 6.
    Davda R, Peterson J, Weiner R, et al.: Membranous glomerulonephritis in association with hepatitis C virus infection. Am J Kidney Dis 1993, 22:452–455.PubMedGoogle Scholar
  7. 7.
    Stehman-Breen C, Willson R, Alpers C, et al.: Hepatitis C virus associated membranous glomerulonephritis. Curr Opin Nephrol Hypertens 1995, 4:287–294.PubMedCrossRefGoogle Scholar
  8. 8.
    Pol S, Thiers V, Carnot F, et al.: Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients. Kidney Int 1995, 47:1412–1418.PubMedGoogle Scholar
  9. 9.
    Selby P, Kohn J, Raymond J, et al.: Nephrotic syndrome during treatment with interferon. Br Med J 1985, 290:1180.Google Scholar
  10. 10.
    Usalan C, Erdem Y, Altun B, et al.: Rapidly progressive glomerulonephritis associated with hepatitis C virus infection. Clin Nephrol 1998, 49:129–131. A case report of a 20-year-old woman who developed rapidly progressive glomerulonephritis during the course of active HCV infection. Whether this is a true association or a coincidental finding is unknown.PubMedGoogle Scholar
  11. 11.
    Coroneos E, Truong L, Olivero J: Fibrillary glomerulonephritis associated with hepatitis C viral infection. Am J Kidney Dis 1997, 29:132–135.PubMedGoogle Scholar
  12. 12.
    Markowitz GS, Cheng JT, Colvin RB, et al.: Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol 1998, 9:2244–2252. Report of four cases of fibrillary glomerulonephritis and two cases of immunotactoid glomerulopathy in association with HCV infection. Outcomes were variable.PubMedGoogle Scholar
  13. 13.
    Ferri C, Greco F, Longombardo G, et al.: Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991, 19:417–420.PubMedCrossRefGoogle Scholar
  14. 14.
    Ferri C, Greco F, Longombardo G, et al.: Hepatitis C virus antibodies in mixed cryoglobulinemia. Clin Exper Rheumatol 1991, 9:95–96.Google Scholar
  15. 15.
    Stokes MB, Chawla H, Brody RI, et al.: Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 1997, 29:514–525.PubMedGoogle Scholar
  16. 16.
    Morales E, Alegre R, Herrero JC, et al.: Hepatitis-C-virusassociated cryoglobulinaemic membranoproliferative glomerulonephritis in patients infected by HIV. Nephrol Dial Transplant 1997, 12:1980–1984.PubMedCrossRefGoogle Scholar
  17. 17.
    Rivera M, Gonzalo A, Maqmpaso, et al.: The heterogeneity of glomerulonephritis associated with HIV. Nephrol Dial Transplant 1999, 14:244–245. Report of four patients with HCV/HIV co-infection who were noted to have the following renal histopathologies: membranous nephropathy in two patients, focal segmental glomerulosclerosis in one, and diffuse proliferative glomerulonephritis in the other.PubMedCrossRefGoogle Scholar
  18. 18.
    Beaufils H, Jouanneau C, Katlama C, et al.: HIV-associated IgA nephropathy: a postmortem study. Nephrol Dial Transplant 1995, 10:35–38.PubMedGoogle Scholar
  19. 19.
    Horikoshi S, Okada T, Shirato I, et al.: Diffuse proliferative glomerulonephritis with hepatitis C virus-like particles in paramesangial dense deposits in a patient with chronic hepatitis C virus hepatitis. Nephron 1993, 64:482–484.CrossRefGoogle Scholar
  20. 20.
    Pucillo L, Agnello V: Membranoproliferative glomerulonephritis associated with hepatitis B and C viral infections: from virus-like particles in the cryoprecipitate to viral localization in paramesangial deposits, problematic investigations prone to artifacts. Curr Opin Nephrol Hypertens 1994, 3:465–470.PubMedCrossRefGoogle Scholar
  21. 21.
    Fornasieri A, Armelloni S, Bernasconi P, et al.: High binding of immunoglobulin M kappa rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Dis 1996, 27:476–483.PubMedGoogle Scholar
  22. 22.
    Sansonno D, Gesualdo L, Manno C, et al.: Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997, 25:1237–1244.PubMedCrossRefGoogle Scholar
  23. 23.
    Misiani R, Bellavita P, Fenili D, et al.: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994, 330:751–756.PubMedCrossRefGoogle Scholar
  24. 24.
    Sarac E, Bastacky S, Johnson JP: Response to high-dose alfa interferon after failure of standard therapy in MPGN associated with HCV infection. Am J Kidney Dis 1997, 30:113–115.PubMedGoogle Scholar
  25. 25.
    Johnson RJ, Gretch DR, Couser WG, et al.: Hepatitis C virusassociated glomerulonephritis.: effect of alpha-interferon therapy. Kidney Int 1994, 46:1700–1704.PubMedGoogle Scholar
  26. 26.
    Morosetti M, Sciarra G, Meloni C, et al.: Membranoproliferative glomerulonephritis and hepatitis C: effects of interferon-alpha therapy on clinical outcome and histological pattern. Nephrol Dial Transplant 1996, 11:532–534.PubMedGoogle Scholar
  27. 27.
    Polynard T, Leroy V, Cohard M, et al.: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996, 24:778–789.CrossRefGoogle Scholar
  28. 28.
    Baid S, Pascual M, Williams W, et al.: Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft receipients. J Am Soc Nephrol 1999, 10:146–153. According to this report, all five patients (out of 18 recipients of HCVpositive serology pretransplant) with biopsy-proven de novo renal thrombotic microangiopathy (RTMA) had a positive ACA test, compared with only one of 13 patients without RTMA. The occurrence of this condition may reflect unfavorable outcome for patient and graft survival.PubMedGoogle Scholar
  29. 29.
    Legendre CH, Garrigue V, Le Bihan C, et al.: Harmful long-term impact of hepatitis C virus infection in kidney transplant receipients. Transplantation 1998, 65:667–670. Report on a retrospective study from France comparing patient survival and cause of death among anti-HCV-positive (n=387) and - negative (n=112) transplant recipients. Anti-HCV-positive patients had significantly shorter patient and graft long-term survival than anti-HCV-negative patients. Increased mortality was primarily due to liver disease and sepsis.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Marie Philipneri
    • 1
  • Bahar Bastani
    • 1
  1. 1.Division of NephrologySaint Louis University School of MedicineSt. LouisUSA

Personalised recommendations